Roger Royster to Amrinone
This is a "connection" page, showing publications Roger Royster has written about Amrinone.
Connection Strength
0.366
-
Royster RL, Butterworth JF, Prielipp RC, Zaloga GP, Lawless SG, Spray BJ, Kon ND, Wallenhaupt SL, Cordell AR. Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. Anesth Analg. 1993 Oct; 77(4):662-72.
Score: 0.120
-
Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone. Chest. 1992 Jan; 101(1):174-80.
Score: 0.106
-
Prielipp RC, Butterworth JF, Zaloga GP, Robertie PG, Royster RL. Effects of amrinone on cardiac index, venous oxygen saturation and venous admixture in patients recovering from cardiac surgery. Chest. 1991 Apr; 99(4):820-5.
Score: 0.101
-
Butterworth JF, Royster RL, Prielipp RC, Lawless ST, Wallenhaupt SL. Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial. Chest. 1993 Dec; 104(6):1660-7.
Score: 0.030
-
Butterworth JF, Legault C, Royster RL, Hammon JW. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg. 1998 Mar; 86(3):461-7.
Score: 0.010